Evidence map›Paper›PMID 32453505›Full record

ArticleACR open rheumatology2020

Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis.

Zoe Brown, Robert Metcalf, Jana Bednarz, Llewellyn Spargo, Anita Lee, Catherine Hill, Mihir Wechalekar, Christiana Stavrou, Michael James, Les Cleland and 1 more

Open access · goldAbstract read
In one paragraph

Article in ACR open rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Zoe BrownRoyal Adelaide Hospital, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0002-4973-8212
Robert MetcalfRoyal Adelaide Hospital, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0002-0069-0019
Jana BednarzUniversity of Adelaide, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0002-5517-1638
Llewellyn SpargoRoyal Adelaide Hospital, Adelaide, South Australia, Australia.
Anita LeeRoyal Adelaide Hospital, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0003-1369-3793
Catherine HillRoyal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0001-8289-4922
Mihir WechalekarFlinders Medical Centre and Flinders University, Bedford Park, South Australia, Australia.ORCID https://orcid.org/0000-0001-6668-9638
Christiana StavrouUniversity College London Hospital, London, UK.
Michael JamesRoyal Adelaide Hospital, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0002-6823-8520
Les ClelandRoyal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0001-7236-9630
Susanna ProudmanRoyal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia.ORCID https://orcid.org/0000-0002-3046-9884
Royal Adelaide Hospital · AUFlinders University · AUThe University of Adelaide · AUUniversity College Hospital · GB

Funding

Melrose Health
6 · The paper itself

Abstract

objectiveWe aimed to evaluate the associations between response to algorithm-directed treat-to-target conventional synthetic disease-modifying antirheumatic drug therapy and potentially modifiable lifestyle factors, including dietary fish oil supplementation, body mass index (BMI), and smoking history in a rheumatoid arthritis (RA) inception cohort.

methodsPatients with RA with a duration of less than 12 months were reviewed every 3 to 6 weeks to adjust therapy according to disease response. All patients received advice to take fish oil supplements, and omega-3 status was measured as plasma levels of eicosapentaenoic acid (EPA). Lifestyle factors and other variables potentially prognostic for 28-joint Disease Activity Score (DAS28) remission and DAS28 low disease activity (LDA) at the 12-month visit were included in multivariable logistic regression models.

resultsOf 300 participants, 57.7% reached DAS28 LDA, and 43.7% were in DAS28 remission at 1 year. Increase in plasma EPA was associated with an increase in the odds of being in LDA (adjusted odds ratio [OR] = 1.27; P < 0.0001) and remission (adjusted OR = 1.21; P < 0.001). There was some evidence that the effect of BMI on LDA might be modified by smoking history. An increase in BMI was associated with a decrease in the odds of being in LDA in current and former smokers but had no impact on LDA in patients who had never smoked. There were no meaningful associations between BMI or smoking history and remission.

conclusionOmega-3 status, BMI, and smoking history are potential predictors of outcome in early RA. The possibility of an effect modification by smoking on the predictive value of BMI merits further investigation.

Identifiers

PMID32453505
PMCPMC7301874
OpenAlexW3032769717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.